Prostatic adenocarcinoma of ductal origin

Cancer

Volumn 32, Issue 2, 1973, Pages 402-409

  Dube, Volkjer E ^a   Farrow, George M ^b   Greene, Laurence F ^b  

^a ST JOSEPH MERCY HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE CANCER; PROSTATE CARCINOMA;

ACID PHOSPHATASE; ADULT; AGED; BONE NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; ESTROGENS; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; NEOPLASM METASTASIS; PALLIATIVE CARE; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 0015836139     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(197308)32:2<402::AID-CNCR2820320218>3.0.CO;2-Q     Document Type: Article

References (15)

1. Histogenesis of prostatic carcinomas
2. Papillomatosis and papillary adenocarcinoma of prostatic ducts: A case report
3. Papillary primary duct adenocarcinoma of the prostate
4. Endocrine therapy in carcinoma of the prostate gland: 10‐year survival studies
5. Clinical cancer of the prostate: A study of 4,000 cases
6. Carcinoma of the prostate: A review of 162 cases with a pathologic classification
7. Carcinoma of the prostate gland: A pathologic study
8. Histochemistry of the normal, hyperplastic, and neoplastic human prostate gland
9. Correlative histochemical and hlstological studies on thirty radical prostatectomy specimens
10. Endometrial carcinoma of uterus masculinus (prostatic utricle): Report of 6 cases
11. The morphology of small prostatic carcinoma
12. Endocrine control of prostatic carcinoma: Clinical and statistical survey of 1,818 cases
13. Prostatic carcinoma: a follow‐up on 795 patients treated prior to the endocrine era and a comparison of survival rates between these and patients treated by endocrine therapy
14. Conservative treatment of carcinoma of the prostate
15. Comment: The penultimate in cancer diagnosis—enzymology